REVB (Revelation Biosciences Inc) Net Profit

REVB (Revelation Biosciences, Inc.) - company brandmark

Revelation Biosciences is implementing AI and robotics to automate the creation of immune-based medicines. The company's financial results demonstrate current business resilience, where -0.02 represents the latest metric reading. The enterprise aims to outpace competitors in clinical trials, while management focuses on developing therapies for innate immunity activation to attract strategic partners.

REVB (Revelation Biosciences) Net Profit history from 07/04/2022 to 10/30/2026
Core merchandise of Revelation Bio

For the biopharmaceutical startup Revelation Biosciences (REVB), this indicator serves as a tool to monitor the burn rate of available resources until the commercialization of its drugs. By analyzing the company's profit, an investor assesses the daily price action of net income, where a lack of positive momentum and a stagnating trend line confirm a survival model based on capital burn rather than operational business efficiency.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|PGEN - Company Net Income|Final Profit PHAR (Pharming Corp)|NKTR: Net Profit|Company Net Income upstreambio.com (UPB)|Net Income ZBIO|Company Net Income IMNM|Net Profit GOSS|KALV - Company Net Income|Company Net Income Septerna Inc SEPN|pieris.com - Company Net Income|Savara - Net Profit|RIGL - Net Profit|ANAB (AnaptysBio Corp) - Net Income|ATXS: Profit After Payment of Taxes|ENGN (enGene Holdings Inc.) - Net Profit|rapt.com (RAPT) - Net Financial Result|Company Net Income Aerovate Therapeutics Inc (JBIO)|ACRS - Company Net Income|Company Net Income Kyverna KYTX|TLSA: Company Profit|CABA: Net Income|Final Profit VTYX (ventyxbio.com)|THTX: Net Profit|AVTX (Avalo Therapeutics, Inc.) - Company Net Income|ELDN (Eledon) - Net Profit|Agenus, Inc (AGEN) - Net Financial Result|Company Net Income Climb Bio Inc (CLYM)|ZURA - Company Net Income|Company Net Income aTyr Pharma ATYR|Net Financial Result Adagene Inc (ADAG)|Ikena Oncology, Inc. - Net Profit|Shattuck Labs, Inc. (STTK) - Net Income|EQ: Net Profit|CNTB - Net Financial Result|IMUX (Immunic Therapeutics) - Net Profit|Company Net Income Atara Biotherapeutics Inc ATRA|Company Net Income InflaRx N.V. (IFRX)|X4 Pharmaceuticals, Inc - Company Profit|Net Profit ACET (Adicet Bio, Inc.)|CELU - Net Income|INmune Bio - Net Profit|Company Net Income Barinthus Biotherapeutics PLC|Kezar Life Sciences, Inc (KZR) - Company Net Income|SABS - Net Financial Result|Company Net Income Akari Therapeutics|ENLV: Final Profit|Net Profit QTTB|GOVX - Company Net Income|Edesa - Net Income|iBio Corporation - Company Net Income|Carisma Tx - Net Profit|XTLB: Company Net Income|boltbio.com (BOLT) - Company Net Income|Profit After Tax HCWB (HCW Biologics)|APVO (Aptevo Therapeutics, Inc.) - Net Profit|AIM: Final Profit|Net Profit ADTX|Net Profit gribio.com (GRI)|Company Net Income XORTX Therapeutics XRTX|Final Profit HIND|INDP - Company Net Income|BiondVax Pharmaceuticals (SCNI) - Net Income|CALI: Net Profit|Affimed N.V. (AFMD) - Net Profit|Net Income ALLK|HOOK: Final Profit|Net Profit IGMS|Net Financial Result iTeos Pharma|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP - Net Income|THRD - Company Net Income